Alfresa Holdings Corporation (TYO:2784)

Japan flag Japan · Delayed Price · Currency is JPY
2,173.50
-9.50 (-0.44%)
Mar 26, 2025, 3:30 PM JST
-4.73%
Market Cap 390.30B
Revenue (ttm) 2.94T
Net Income (ttm) 34.41B
Shares Out 181.79M
EPS (ttm) 184.34
PE Ratio 11.65
Forward PE 13.14
Dividend 64.00 (2.92%)
Ex-Dividend Date Mar 28, 2025
Volume 548,600
Average Volume 534,995
Open 2,181.50
Previous Close 2,183.00
Day's Range 2,143.00 - 2,181.50
52-Week Range 1,929.00 - 2,473.50
Beta -0.10
RSI 59.20
Earnings Date May 15, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements,... [Read more]

Sector Healthcare
Founded 2003
Employees 12,517
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2784
Full Company Profile

Financial Performance

In 2023, Alfresa Holdings's revenue was 2.86 trillion, an increase of 6.02% compared to the previous year's 2.70 trillion. Earnings were 29.56 billion, an increase of 14.63%.

Financial Statements

News

There is no news available yet.